Mechanisms of Acute Nephrotoxicity

Halogenated Aliphatic Hydrocarbons
  • William M. Kluwe


Kidney disease is unquestionably a major contributing factor to health problems in the United States, with renal failure alone estimated to cause up to 100,000 deaths yearly (DHEW-NIH, 1978). Although the proportion of kidney disease directly caused, or contributed to, by chemical exposures is unknown, the common association of some analgesics, antibiotics, and heavy metals with renal dysfunction indicates the innate susceptibility of the human kidney to chemical insult. Occupational and environmental exposures to chemicals other than heavy metals are less clearly associated with nephrotoxicity, possibly because of inadequate patient histories and worker exposure records, insensitive diagnostic tests, and the lack of followup studies. The large population exposed to halogenated aliphatic hydrocarbon compounds at work or in the general environment, in particular, necessitates an assessment of the effects of these potentially nephrotoxic compounds on human renal function.


Aliphatic Hydrocarbon Microsomal Enzyme Proximal Tubular Cell Xenobiotic Metabolism Environmental Toxicant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bunn, W. W., Haas, B. B., Deane, E. R. and Kleopfer, D., 1975, Formation of trihalomenthanes by chlorination of surface water, Environ. Lett. 10:205.CrossRefGoogle Scholar
  2. DHEW-NIH, 1978, Research Needs in Nephrology and Urology. Volume I. Report of the Coordinating Committee, U.S. Department of Health, Education and Welfare Publication No. (NIH) 78–1481.Google Scholar
  3. Fowler, B. A., Hook, G. E. R., and Lucier, G. W., 1977, Tetrachlorodebenzo-p-dioxin induction of renal microsomal enzyme systems: Ultrastructural effects onpars recta (S3) proximal tubule cells of the rat kidney, J. Pharmacol. Exp. Ther. 203:712.Google Scholar
  4. Hook, J. B., 1980, Toxic responses of the kidney, in: Casarett and Doull’s Toxicology (J. Doull, C. D. Klaassen, and M. O. Amdur, eds.), Macmillan, New York, p. 232.Google Scholar
  5. Ilett, K. F., Reid, W. D., Sipes, I. G., and Krishna, G., 1973, Chloroform toxicity in mice: Correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules, Exp. Mol. Pathol. 19:215.CrossRefGoogle Scholar
  6. Jones, A. R., Fakhouri, G., and Gadiel, P., 1979, The metabolism of the soil fumigant 1,2-dibromo-3-chloropropane in the rat, Experientia 35:1432.CrossRefGoogle Scholar
  7. Kluwe, W. M., 1981, The nephrotoxicity of low molecular weight halogenated alkane solvents, pesticides and chemical intermediates, in: Toxicology of the Kidney (J. B. Hook and R. L. Dixon, eds.), Academic Press, New York, p. 179.Google Scholar
  8. Kluwe, W. M., and Hook, J. B., 1978, Polybrominated biphenyl-induced potentiation of chloroform toxicity, Toxicol. Appl. Pharmacol. 45:861.CrossRefGoogle Scholar
  9. Kluwe, W. M., and Hook, J. B., 1981, Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsomal enzyme inhibitor piperonyl butoxide. Toxicol. Appl. Pharmacol. 59:457.CrossRefGoogle Scholar
  10. Kluwe, W. M., McCormack, K. M., and Hook, J. B., 1978, Selective modification of the renal and hepatic toxicities of chloroform by induction of drug-metabolizing enzyme systems in kidney and liver, J. Pharmacol. Exp. Ther. 207:566.Google Scholar
  11. Kluwe, W. M., Herrmann, C. L., and Hook, J. B., 1979, Effects of polychlorinated biphenyls and polybrominated biphenyls on the renal and hepatic toxicities of several chlorinated hydrocarbon solvents in mice, J. Toxicol. Environ. Health 5:605.CrossRefGoogle Scholar
  12. Kluwe, W. M., McNish, R., Smithson, K., and Hook, J. B., 1981, Depletion by 1,2-dibromoethane, 1,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl) phosphate and hexachloro-1,3-butadiene of reduced non-protein sulfhydryl groups in target and non-target organs. Biochem. Pharmacol. 30:2265.CrossRefGoogle Scholar
  13. Mitchell, J. R., McMurtry, R. J., Statham, C. N., and Nelson, S. D., 1977, Molecular basis for several drug-induced nephropathies, Am. J. Med. 62:518.CrossRefGoogle Scholar
  14. Pohl, L. R., George, J. W., Martin, J. L., and Krishna, G., 1979, Deuterium isotope effect in in vivo bioactivation of chloroform to phosgene, Biochem. Pharmacol. 28:561.CrossRefGoogle Scholar
  15. Reichert, D., Werner, H. W., Metzler, M., and Henschler, D., 1979, Molecular mechanisms of 1,1-dichloroethylene toxicity: Excreted metabolites reveal different pathways of reactive intermediates, Arch. Toxicol. 42:159.CrossRefGoogle Scholar
  16. Schreiner, G. E., and Maher, J. F., 1965, Toxic nephropathy, Am. J. Med. 38:409.CrossRefGoogle Scholar
  17. Tune, B. P., Burg, M. B., and Patlak, C. S., 1969, Characteristics of p-aminohippurate transport in proximal renal tubules, Am. J. Physiol. 217:1057.Google Scholar
  18. Zenser, T. V., Mattammal, M. B., and Davis, B. B., 1978, Differential distribution of the mixed-function oxidase activities in rat kidney, J. Pharmacol. Exp. Ther. 207:719.Google Scholar
  19. Zenser, T. V., Mattammal, M. B., and Davis, B. B., 1979, Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney, J. Pharmacol. Exp. Ther. 208:418.Google Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • William M. Kluwe
    • 1
  1. 1.National Toxicology ProgramUSA

Personalised recommendations